Letter by Vos et al regarding article, "Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials"

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation (New York, N.Y.) N.Y.), 2010-12, Vol.122 (23), p.e576; author reply e577-e576; author reply e577
Hauptverfasser:	Vos, Eddie, Rose, Colin P, Biron, Pierre
Format:	Artikel
Sprache:	eng
Schlagworte:	C-Reactive Protein - biosynthesis C-Reactive Protein - metabolism Cardiovascular Diseases - blood Cardiovascular Diseases - prevention & control Clinical Trials as Topic - methods Dyslipidemias - blood Dyslipidemias - drug therapy Female Fluorobenzenes - therapeutic use Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Meta-Analysis as Topic Pyrimidines - therapeutic use Rosuvastatin Calcium Sulfonamides - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!